跳至主要内容
临床试验/ISRCTN18133939
ISRCTN18133939已完成未知

Does ColdZyme® Mouth Spray reduce upper respiratory tract infection incidence or duration in endurance athletes?

niversity of Kent0 个研究点目标入组 114 人开始时间: 2022年9月27日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
114

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Endurance-trained, competitive athletes (e.g. long-distance runners, triathletes, cyclists), with a high training load (i.e. >5 hours planned training and/or activity per week)

排除标准

  • 1. On long-term medication
  • 2. Currently smoking
  • 3. Allergic to any of the ingredients in ColdZyme
  • 4. Currently using any medication (except for contraceptives), or food supplements
  • 5. Currently using any other relevant products or supplements (nutritional or otherwise) that may influence the common cold
  • 6. Currently taking part in another study that may compromise the results of this study
  • 7. Currently pregnant, breast-feeding or planning to become pregnant during the study

研究者

发起方
niversity of Kent

相似试验

Does ColdZyme mouth spray protect athletes against... | 临床试验